At the news
? NEUTRALIMPACT 2/10 6-K filed Nov 12, 2026 at 14:36 ET
Genmab filed a Form 6-K disclosing routine insider share sales by two board members. Board member Martin Schultz sold 617 shares at DKK 3,540.87 and board member Mijke Zachariasse sold 351 shares at the same price, both on November 12, 2026. The filing contains no financial results, guidance, or material corporate events.
- Board member Martin Schultz sold 617 shares at DKK 3,540.87 per share on Nov 12, 2026
- Board member Mijke Zachariasse sold 351 shares at DKK 3,540.87 per share on Nov 12, 2026
- Total proceeds from both sales approximately DKK 3.43 million (about $485,000 at current rates)
- The sales represent a tiny fraction of the company's $33.7B market cap
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access